Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study

Home > Science Hub > Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
Back to the list

November 16, 2023

You might also be interested by

Press Releases

Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials

September 24, 2025

More info

CellTalk Blog

B-Cell Populations in Focus: A New Flow Cytometry Assay for Increased Sensitivity in Autoimmune Research

September 19, 2025

Flow Cytometry

More info

CellTalk Blog

Next-Gen Immune Monitoring: The Value of Single-Cell Sequencing

August 12, 2025

More info

Web News

CellCarta and Tivenix Strategic Partnership

July 21, 2025

More info